Enovis entered into an exclusive partnership with Osteotec to expand its joint reconstruction business in the UK and Ireland. The appointment of Osteotec as an exclusive Enovis agent is expected to be completed by the end of 2022.
The addition of Osteotec adds a channel in the UK and Ireland for Enovis’ joint replacement products, including the Altivate Reverse shoulder replacement system, EMPOWR products and extremity solutions. The partnership also includes surgical solutions from Mathys, an Enovis company, including the Affinis Short shoulder system and hip solutions such as the RM – Cup and Optimys hip stem.
Andrew Jones, Vice President of Business Development of Enovis International, said, “Osteotec’s differentiated products, deep expertise and talented commercial team will help us accelerate our strategic imperative of delivering superior patient outcomes in this very important market.”
“This exclusive agency agreement builds upon the shared values of both companies, giving our customers more focused support than ever before,” said Anthony McClellan, Osteotec Group General Manager. “We look forward to working with the Enovis team to grow and support sales through our expertise.”
Enovis entered into an exclusive partnership with Osteotec to expand its joint reconstruction business in the UK and Ireland. The appointment of Osteotec as an exclusive Enovis agent is expected to be completed by the end of 2022.
The addition of Osteotec adds a channel in the UK and Ireland for Enovis’ joint replacement products, including...
Enovis entered into an exclusive partnership with Osteotec to expand its joint reconstruction business in the UK and Ireland. The appointment of Osteotec as an exclusive Enovis agent is expected to be completed by the end of 2022.
The addition of Osteotec adds a channel in the UK and Ireland for Enovis’ joint replacement products, including the Altivate Reverse shoulder replacement system, EMPOWR products and extremity solutions. The partnership also includes surgical solutions from Mathys, an Enovis company, including the Affinis Short shoulder system and hip solutions such as the RM – Cup and Optimys hip stem.
Andrew Jones, Vice President of Business Development of Enovis International, said, “Osteotec’s differentiated products, deep expertise and talented commercial team will help us accelerate our strategic imperative of delivering superior patient outcomes in this very important market.”
“This exclusive agency agreement builds upon the shared values of both companies, giving our customers more focused support than ever before,” said Anthony McClellan, Osteotec Group General Manager. “We look forward to working with the Enovis team to grow and support sales through our expertise.”
Copy to clipboard 
